Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 33

1.
2.

Factors influencing the economics of biosimilars in the US.

Mehr SR, Brook RA.

J Med Econ. 2017 Dec;20(12):1268-1271. doi: 10.1080/13696998.2017.1366325. Epub 2017 Aug 29. No abstract available.

PMID:
28796564
3.

The Use Comparative Effectiveness Research And Evidence Based Medicine In Us Payor Decision Making.

Sax MJ, Smeeding JE, Brook RA.

Value Health. 2015 Nov;18(7):A541. doi: 10.1016/j.jval.2015.09.1710. Epub 2015 Oct 20. No abstract available.

4.

The Current Landscape And Expected Changes In Formulary Management.

Brook RA, Smeeding JE, Sax MJ.

Value Health. 2015 Nov;18(7):A528. doi: 10.1016/j.jval.2015.09.1637. Epub 2015 Oct 20. No abstract available.

5.

The United States Specialty Pharmacy Payor Landscape.

Brook RA, Smeeding JE, Sax MJ.

Value Health. 2015 Nov;18(7):A528. doi: 10.1016/j.jval.2015.09.1635. Epub 2015 Oct 20. No abstract available.

6.

Specialty pharmaceuticals and the quest for better outcomes.

Brook RA.

J Med Econ. 2016;19(1):63-9. doi: 10.3111/13696998.2015.1091351. Epub 2015 Oct 6.

PMID:
26357895
7.

Costs and absence of HCV-infected employees by disease stage.

Baran RW, Samp JC, Walker DR, Smeeding JE, Young JW, Kleinman NL, Brook RA.

J Med Econ. 2015;18(9):691-703. doi: 10.3111/13696998.2015.1045423. Epub 2015 Jun 11.

PMID:
26047262
8.

United States comparative costs and absenteeism of diabetic ophthalmic conditions.

Brook RA, Kleinman NL, Patel S, Smeeding JE, Beren IA, Turpcu A.

Postgrad Med. 2015 Jun;127(5):455-62. doi: 10.1080/00325481.2014.994468. Epub 2014 Dec 31.

PMID:
25549691
9.

Annual incremental health benefit costs and absenteeism among employees with and without rheumatoid arthritis.

Kleinman NL, Cifaldi MA, Smeeding JE, Shaw JW, Brook RA.

J Occup Environ Med. 2013 Mar;55(3):240-4. doi: 10.1097/JOM.0b013e318282d310.

PMID:
23471034
10.

Absenteeism and productivity among employees being treated for hepatitis C.

Brook RA, Kleinman NL, Su J, Corey-Lisle PK, Iloeje UH.

Am J Manag Care. 2011 Oct;17(10):657-64.

PMID:
22106459
11.

Excess comorbidity prevalence and cost associated with functional dyspepsia in an employed population.

Brook RA, Kleinman NL, Choung RS, Smeeding JE, Talley NJ.

Dig Dis Sci. 2012 Jan;57(1):109-18. doi: 10.1007/s10620-011-1822-8. Epub 2011 Jul 13.

PMID:
21750928
12.

Comparing costs and absences for multiple sclerosis among US employees: pre- and post-treatment initiation.

Rajagopalan K, Brook RA, Beren IA, Kleinman NL.

Curr Med Res Opin. 2011 Jan;27(1):179-88. doi: 10.1185/03007995.2010.540006. Epub 2010 Dec 7.

PMID:
21138336
13.

Chronic gout: epidemiology, disease progression, treatment and disease burden.

Brook RA, Forsythe A, Smeeding JE, Lawrence Edwards N.

Curr Med Res Opin. 2010 Dec;26(12):2813-21. doi: 10.1185/03007995.2010.533647. Epub 2010 Nov 4. Review.

PMID:
21050059
14.

Medication adherence with disease modifying treatments for multiple sclerosis among US employees.

Kleinman NL, Beren IA, Rajagopalan K, Brook RA.

J Med Econ. 2010;13(4):633-40. doi: 10.3111/13696998.2010.527588. Epub 2010 Oct 19.

PMID:
20958113
15.

The impact of hepatitis C virus infection on work absence, productivity, and healthcare benefit costs.

Su J, Brook RA, Kleinman NL, Corey-Lisle P.

Hepatology. 2010 Aug;52(2):436-42. doi: 10.1002/hep.23726.

PMID:
20683943
16.

Functional dyspepsia impacts absenteeism and direct and indirect costs.

Brook RA, Kleinman NL, Choung RS, Melkonian AK, Smeeding JE, Talley NJ.

Clin Gastroenterol Hepatol. 2010 Jun;8(6):498-503. doi: 10.1016/j.cgh.2010.03.003. Epub 2010 Mar 19.

PMID:
20304102
17.

Add-back therapy use and its impact on LA persistence in patients with endometriosis.

Fuldeore MJ, Marx SE, Chwalisz K, Smeeding JE, Brook RA.

Curr Med Res Opin. 2010 Mar;26(3):729-36. doi: 10.1185/03007990903582985.

PMID:
20092387
18.

Health benefit costs and absenteeism due to insomnia from the employer's perspective: a retrospective, case-control, database study.

Kleinman NL, Brook RA, Doan JF, Melkonian AK, Baran RW.

J Clin Psychiatry. 2009 Aug;70(8):1098-104. doi: 10.4088/JCP.08m04264.

PMID:
19758521
19.

An employer perspective on annual employee and dependent costs for pediatric asthma.

Kleinman NL, Brook RA, Ramachandran S.

Ann Allergy Asthma Immunol. 2009 Aug;103(2):114-20. doi: 10.1016/S1081-1206(10)60163-9.

PMID:
19739423
20.

Absenteeism and health-benefit costs among employees with MS.

Brook RA, Rajagopalan K, Kleinman NL, Melkonian AK.

Curr Med Res Opin. 2009 Jun;25(6):1469-76. doi: 10.1185/03007990902905468.

PMID:
19422277

Supplemental Content

Loading ...
Support Center